518.8500 -15.45 (-2.89%)
NSE Jan 23, 2026 15:31 PM
Volume: 41,018
 

518.85
-2.89%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters unpledged 9.28% of shares in last quarter. Total pledge stands at 26.04% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended